Gantenerumab does not slow cognitive decline in early Alzheimer’s
1. In these two randomized parallel-group trials, the use of gantenerumab did not lead to slower cognitive decline over 116 ...
Tag: amyloid plaque
#VisualAbstract: Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
1. While well-tolerated in early and mild Alzheimer’s disease, the BACE1 inhibitor lanabecestat was generally ineffective in slowing cognitive and ...
Alzheimer’s Disease imaging biomarkers slightly improve prediction of memory decline
1. In this prospective cohort, Alzheimer’s Disease biomarkers derived from imaging, namely amyloid, tau, and cortical thickness estimates, had a ...
Amyloid-PET imaging leads to changes in management in patients with dementia
1. In this prospective cohort study, changes in clinical management occurred after amyloid-PET imaging for a majority of patients with ...